IL10 and autoimmune thrombocytopenic purpura: However, the effect of rituximab treatment in ITP remains difficult to interpret as B cell depletion may also affect CD20+ regulatory B cells, which can secrete IL-10 and other suppressive cytokines to induce immune tolerance (163), as suggested previously.